ScholarLens Back to search
2003•Lung CancerRequires access

P-26 Phase II trial with RFS 2000 (9NC) in patients with advanced and/or metastatic non-small cell lung cancer (NSCLC)

Sofia Baka, Paul Lorigan, Sarah Danson, Alison White, Patrick F. Joyce, Nick Thatcher, Malcolm Ranson

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Oncology, non-small cell lung cancer (NSCLC), Internal medicine, Lung cancer, A549 cell

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
P-26 Phase II trial with RFS 2000 (9NC) in patients with advanced and/or metastatic non-small cell lung cancer (NSCLC) — Research Paper | ScholarLens